206 related articles for article (PubMed ID: 23121989)
21. Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study.
Lacroix I; Berrebi A; Garipuy D; Schmitt L; Hammou Y; Chaumerliac C; Lapeyre-Mestre M; Montastruc JL; Damase-Michel C
Eur J Clin Pharmacol; 2011 Oct; 67(10):1053-9. PubMed ID: 21538146
[TBL] [Abstract][Full Text] [Related]
22. A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.
Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L
Addiction; 2015 Apr; 110(4):646-55. PubMed ID: 25516077
[TBL] [Abstract][Full Text] [Related]
23. Patterns of non-compliant buprenorphine, levomethadone, and methadone use among opioid dependent persons in treatment.
Casati A; Piontek D; Pfeiffer-Gerschel T
Subst Abuse Treat Prev Policy; 2014 May; 9():19. PubMed ID: 24885218
[TBL] [Abstract][Full Text] [Related]
24. Once-monthly subcutaneous buprenorphine (Sublocade) for opioid use disorder.
Med Lett Drugs Ther; 2018 Feb; 60(1541):35-37. PubMed ID: 29485976
[No Abstract] [Full Text] [Related]
25. A comparison of cognitive function in patients under maintenance treatment with heroin, methadone, or buprenorphine and healthy controls: an open pilot study.
Soyka M; Limmer C; Lehnert R; Koller G; Martin G; Küfner H; Kagerer S; Haberthür A
Am J Drug Alcohol Abuse; 2011 Nov; 37(6):497-508. PubMed ID: 21851203
[TBL] [Abstract][Full Text] [Related]
26. Prenatal exposure to methadone or buprenorphine impairs cognitive performance in young adult rats.
Kongstorp M; Bogen IL; Stiris T; Andersen JM
Drug Alcohol Depend; 2020 Jul; 212():108008. PubMed ID: 32402939
[TBL] [Abstract][Full Text] [Related]
27. Topiramate impairs cognitive function in methadone-maintained individuals with concurrent cocaine dependence.
Rass O; Umbricht A; Bigelow GE; Strain EC; Johnson MW; Mintzer MZ
Psychol Addict Behav; 2015 Mar; 29(1):237-46. PubMed ID: 25365653
[TBL] [Abstract][Full Text] [Related]
28. Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment.
Maremmani I; Gerra G
Am J Addict; 2010; 19(6):557-68. PubMed ID: 20958853
[TBL] [Abstract][Full Text] [Related]
29. A randomized controlled trial of the effects of working memory training in methadone maintenance patients.
Rass O; Schacht RL; Buckheit K; Johnson MW; Strain EC; Mintzer MZ
Drug Alcohol Depend; 2015 Nov; 156():38-46. PubMed ID: 26404954
[TBL] [Abstract][Full Text] [Related]
30. Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol.
Terasaki D; Smith C; Calcaterra SL
Pharmacotherapy; 2019 Oct; 39(10):1023-1029. PubMed ID: 31348544
[TBL] [Abstract][Full Text] [Related]
31. A clinical trial on the acute effects of methadone and buprenorphine on actual driving and cognitive function of healthy volunteers.
Strand MC; Vindenes V; Gjerde H; Mørland JG; Ramaekers JG
Br J Clin Pharmacol; 2019 Feb; 85(2):442-453. PubMed ID: 30515857
[TBL] [Abstract][Full Text] [Related]
32. Cognitive Outcomes of Young Children After Prenatal Exposure to Medications for Opioid Use Disorder: A Systematic Review and Meta-analysis.
Nelson LF; Yocum VK; Patel KD; Qeadan F; Hsi A; Weitzen S
JAMA Netw Open; 2020 Mar; 3(3):e201195. PubMed ID: 32186745
[TBL] [Abstract][Full Text] [Related]
33. The New Kid on the Block--Incorporating Buprenorphine into a Medical Toxicology Practice.
Wiegand TJ
J Med Toxicol; 2016 Mar; 12(1):64-70. PubMed ID: 26574020
[TBL] [Abstract][Full Text] [Related]
34. Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine.
Moody DE
Expert Opin Drug Metab Toxicol; 2013 Jun; 9(6):675-97. PubMed ID: 23537174
[TBL] [Abstract][Full Text] [Related]
35. Methadone versus buprenorphine for the treatment of opioid abuse in pregnancy: science and stigma.
Holbrook AM
Am J Drug Alcohol Abuse; 2015; 41(5):371-3. PubMed ID: 26154531
[TBL] [Abstract][Full Text] [Related]
36. Comparison of QTc interval prolongation for patients in methadone versus buprenorphine maintenance treatment: a 5-year follow-up.
Fareed A; Patil D; Scheinberg K; Blackinton Gale R; Vayalapalli S; Casarella J; Drexler K
J Addict Dis; 2013; 32(3):244-51. PubMed ID: 24074190
[TBL] [Abstract][Full Text] [Related]
37. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
[TBL] [Abstract][Full Text] [Related]
38. DYNAMICS OF OPIOID SUBSTITUTION TREATMENTIN DIFFERENT INITIAL SUBSTANCE USER OPIOID DEPENDENT PATIENTS.
Todadze Kh; Mosia S
Georgian Med News; 2016 May; (254):56-61. PubMed ID: 27348169
[TBL] [Abstract][Full Text] [Related]
39. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
Curcio F; Franco T; Topa M; Baldassarre C;
Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):871-4. PubMed ID: 21845796
[TBL] [Abstract][Full Text] [Related]
40. Salivary cortisol levels relate to cognitive performance in children prenatally exposed to methadone or buprenorphine.
Konijnenberg C; Melinder A
Dev Psychobiol; 2020 Apr; 62(3):409-418. PubMed ID: 31564069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
